These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37810555)

  • 21. Retracted: Delicaflavone Represses Lung Cancer Growth by Activating Antitumor Immune Response through N6-Methyladenosine Transferases and Oxidative Stress.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9856261. PubMed ID: 37388525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9870383. PubMed ID: 37621621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retracted: C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9864592. PubMed ID: 37593080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retracted: Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9758648. PubMed ID: 38189012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retracted: HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
    International BR
    Biomed Res Int; 2024; 2024():9789013. PubMed ID: 38550155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
    Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
    Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retracted: Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9758427. PubMed ID: 37475952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
    Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
    Front Oncol; 2021; 11():611038. PubMed ID: 33937022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retracted: Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
    International BR
    Biomed Res Int; 2024; 2024():9848746. PubMed ID: 38550141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retracted: Identification of Immune-Related Prognostic Markers in Gastric Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862096. PubMed ID: 37772021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retracted: Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
    International BR
    Biomed Res Int; 2024; 2024():9834610. PubMed ID: 38550158
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Wang Z; Ge X; Shi J; Lu B; Zhang X; Huang J
    Oxid Med Cell Longev; 2022; 2022():6711085. PubMed ID: 36062185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9893576. PubMed ID: 37387801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.
    Wang F; Zhao F; Zhang L; Xiong L; Mao Q; Liu Y; Qiu X; Wang X; Shui L; Chen X; Ren K; Shui P; Zhang Q; Deng Y; Li W; Xie X; Wu D; Li T; Lang J; Liu L; Chen H; Xu J; Bai S; Li Z; Yue Q; Chen N; Zhou B; Yi C; Wei Y; Fu Y; Luo Y; Gou Q; Liu L; Liu Y; Kang J; Wang J; Jing D; Zhang F; Yang X; Li X; Jiang T; Zhang Z; Zhou Y; Yi J
    Mol Cancer; 2022 Jul; 21(1):153. PubMed ID: 35879762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retracted: Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma.
    Markers D
    Dis Markers; 2023; 2023():9823853. PubMed ID: 37387735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma.
    Zhu H; Hu X; Feng S; Li Y; Zhang Y; Qiu S; Chen R; Ye Y; Gu L; Jian Z; Xu X; Xiong X
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.